Table 1. Non-serious adverse events.
| Disorder | SAE | CPHPC | Placebo |
|---|---|---|---|
| Cardiac | Hypertension | 1/20 (5.00%) | 0/20 (0.00%) |
| Blood & lymphatics | Enlarged lymph node in neck | 0/20 (0.00%) | 1/20 (5.0%) |
| General | Headache | 4/20 (20.00%) | 7/20 (35.00%) |
| Fatigue | 2/20 (10.00%) | 5/20 (25.00%) | |
| Insomnia | 1/20 (5.00%) | 1/20 (5.00%) | |
| Pain | 1/20 (5.00%) | 0/20 (0.00%) | |
| Dizziness | 0/20 (0.00%) | 1/20 (5.00%) | |
| Fever | 0/20 (0.00%) | 2/20 (10.00%) | |
| Rigors | 0/20 (0.00%) | 2/20 (10.00%) | |
| Gastrointestinal | Diarrhoea | 1/20 (5.00%) | 0/20 (0.00%) |
| Dysphasia | 2/20 (10.00%) | 1/20 (5.00%) | |
| Nausea | 1/20 (5.00%) | 2/20 (10.00%) | |
| Vomiting | 0/20 (0.00%) | 1/20 (5.00%) | |
| Anorexia | 0/20 (0.00%) | 1/20 (5.00%) | |
| Renal & urinary | Abnormal odour | 0/20 (0.00%) | 1/20 (5.00%) |
| Skin & subcutaneous | Rash | 2/20 (10.00%) | 2/20 (10.00%) |
| Musculoskeletal | Injection site reaction | 9/20 (45.00%) | 12/20 (60.00%) |
| Myalgia | 7/20 (35.00%) | 8/20 (40.00%) | |
| Neck stiffness | 0/20 (0.00%) | 1/20 (5.00%) | |
| Infections & infestations | Coryzal symptoms | 0/20 (0.00%) | 2/20 (10.00%) |
| Total | All | 13/20 (65.00%) | 16/20 (80.00%) |